Sompharmaceuticals

About:

Sompharmaceuticals is a Swiss biopharmaceutical company.

Website: http://sompharmaceuticals.com

Twitter/X: amrytpharma

Top Investors: Foundation for Innovation and Technology (FIT)

Description:

Sompharmaceuticals is a Swiss biopharmaceutical company based at the Biopôle in Epalinges-Lausanne, Switzerland. Their focus is on developing novel anti-tumour somatostatin analogue (SSA) peptide medicines and diagnostics for patients with rare diseases, which have unmet medical needs and major market opportunities, including growth hormone producing pituitary brain tumours (acromegaly) and malignant neuroendocrine hormone producing intestinal and pancreatic tumours (NETs) that are resistant or poorly controlled with currently available SSA treatments, octreotide and lanreotide.

Total Funding Amount:

850000 CHF

Headquarters Location:

Epalinges, Vaud, Switzerland

Founded Date:

2012-01-01

Contact Email:

barry.ahern(AT)bmcomms.ie

Founders:

Alan G. Harris

Number of Employees:

1-10

Last Funding Date:

2014-04-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai